Caricamento...

Profile of omalizumab in the treatment of chronic spontaneous urticaria

Chronic spontaneous urticaria (CSU) is a disease with significant morbidity and relative prevalence that has important effects on the quality of life (QoL) of those who suffer from it. Omalizumab is a recombinant humanized anti-immunoglobulin E (IgE) antibody that binds to the Cε3 domain of the IgE...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Drug Des Devel Ther
Autori principali: Labrador-Horrillo, Moises, Ferrer, Marta
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2015
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554406/
https://ncbi.nlm.nih.gov/pubmed/26346472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S56004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !